Cohere is not a household name the way OpenAI or Anthropic is. In a private market marketplace, that relative obscurity is exactly why secondary buyers tend to either ignore it entirely or develop strong conviction without doing the structural work. If you're still building foundational context on how pre-IPO investing and secondary AI markets function before evaluating enterprise infrastructure companies, review the complete guide to pre-IPO investing. Both mistakes cost money.
The company targets enterprise customers — banks, healthcare systems, logistics operators — who want large-language-model capabilities deployed inside their own data perimeters rather than routed through a shared cloud API. That on-premise or private-cloud positioning is a deliberate strategic choice, not a limitation.
The question every buyer should answer first
Before asking what Cohere is worth, ask what you are actually buying access to. Enterprise AI infrastructure is a market where the winner may not be the most technically impressive model — it is often the vendor whose procurement process, legal framework, and data-security documentation large companies can navigate without a year of internal approvals.
Cohere has made that procurement pathway a core part of its pitch. The relevant buyer question is: does that advantage compound over time, or does it erode as larger hyperscalers and established software vendors build equivalent compliance infrastructure? Secondary pricing reflects the market's current answer to that question. Yours may differ.
Reading the valuation mark
As of mid-2026 the most recent reported primary round established a reference mark that secondary transactions price against, typically at a discount. That discount — sometimes called the secondary mark — reflects a bundle of risks: illiquidity, potential dilution from future rounds, and the possibility that a strategic buyer or IPO takes longer than modeled.
For Cohere specifically, buyers have debated two structural concerns. First, the company operates in a segment where contract values are large but sales cycles are long. Revenue can look lumpy quarter to quarter, making near-term 409A valuations — the IRS-approved appraisals private companies use to price stock options — sensitive to deal timing. Second, the competitive set has widened: Microsoft, Google, and Amazon each have enterprise AI products with existing relationships inside Fortune 500 procurement teams.
Supply dynamics on the secondary market
Cohere supply on secondary platforms has historically been thin relative to the more-discussed names like Stripe or Databricks. Thin supply can feel bullish — not many sellers — but it also creates execution risk. When a buyer places an indication on a lightly traded name, the probability that a matched seller holds a specific lot with a clean transfer path is lower than on a liquid name.
Confirmed supply matters more than listed supply. A listing that cannot clear the company's right of first refusal (ROFR) process — where the company can step in and buy shares at the agreed price before they transfer to you — is not real supply until the ROFR window closes without the company exercising.
At Limen Markets, Cohere indications are matched only against confirmed seller-side supply, and ROFR clearance runs in parallel with execution rather than sequentially. That parallel track matters on a name where the underlying company has discretion over whether to intervene.
Structure: direct vs. SPV on a thin-liquidity name
When supply is thin, buyers sometimes encounter offerings structured as SPVs (special purpose vehicles) rather than direct transfers. An SPV pools capital from multiple buyers into a single legal entity that holds the underlying shares. The buyer owns an interest in the SPV, not shares directly.
For Cohere exposure this matters in a specific way: some company transfer policies are more permissive toward a single SPV with one transferee line on the cap table than they are toward multiple direct bilateral transfers. An SPV can therefore be a feature, not just a fee structure, on a name where the company actively manages cap-table size.
The trade-off is fees and carry. A typical SPV structure carries a management fee (often 1–2% per year) and carried interest (often 10–20% of gains above a hurdle). On a direct transfer there are no analogous charges — you pay a transaction fee to the marketplace and that is the end of it. Run both scenarios at your expected hold period before deciding which structure to accept.
Practical checklist before placing an indication
- Confirm whether the offering is direct or SPV, and model the total cost of each structure over your intended hold period.
- Ask when the seller acquired their shares and what their cost basis is — motivated sellers near a liquidity need behave differently than holders with long time horizons.
- Check the company's transfer policy for any approval rights beyond ROFR — some companies require board consent for secondary transfers above a threshold size.
- Identify the most recent 409A date and ask how much time has passed; a stale appraisal can mean the secondary price is pricing in more information than the official mark reflects.
- Size the position relative to the illiquidity. A name with thin secondary supply may also have thin exit options before an IPO or acquisition.
Cohere sits at an interesting intersection: genuine enterprise traction, a differentiated positioning story, and a secondary market that has not yet formed the deep liquidity of the larger AI names. That combination rewards buyers who do the structural work and punishes those who treat it as a simpler trade.
View current Cohere pre-IPO shares and confirmed supply on the Limen Markets marketplace, or read our deeper treatment of how to evaluate secondary supply quality before placing any indication.